Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Digestive System Neoplasms » Biliary Tract Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Biliary Tract Diseases » Biliary Tract Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Digestive System Neoplasms » Biliary Tract Neoplasms
Description
Tumors or cancer in the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER. MeSH
Hierarchy View
Subtype Terms (2)
Bile Duct Neoplasms
125 drugs (78 approved, 47 experimental)
Gallbladder Neoplasms
108 drugs (65 approved, 43 experimental)
Phase 3 Indicated Drugs (21)
Phase 2 Indicated Drugs (70)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 3 Indications (24)
Organization Involved with Phase 2 Indications (104)
Academic and Community Cancer Research United
Association of Research on the Biology of Liver Tumors
Cantonal Hospital of St. Gallen
Chinese Academy of Medical Sciences
Hospital de Cancer de Barretos - Fundacao Pio XII
Huazhong University of Science and Technology
IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest
Korean South West Oncology Group
National Cheng Kung University
New Mexico Cancer Care Alliance
Shanghai Junshi Bioscience Co.,Ltd.
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
